The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Agreed. Let that happen and then Airestech float and 2024 might be a good year...
I rarely post here these days but will add my bafflement to the stream. We finally have liquid assets and yet we languish, such is the effect of diabolical comms over years now. I hope to God we haven't sold at this point and keep at least half our CDT shares and sell half around here or better - the $10 mark would be perfect. Perhaps we will re rate once money is in the bank and declared.
Oh and VERY funny that LSE has bleeped that
Regarding MURF shares - can anyone tell me roughly how much each dollar above $15 is effectively worth to us?
Matty, we've been over this today already and it's not too far back in the chat. This from Aceinvestor:
https://www.sec.gov/Archives/edgar/data/1896212/000149315223027856/form424b3.htm
Just search for vela but the important bit is this:
On April 20, 2023, Conduit entered into an agreement with Vela Technologies PLC (“Vela”) which granted Vela the right, but not the obligation, to sell its 8% royalty interest in the Covid Asset back to Conduit (the “Vela Put Option”). In accordance with the Vela Put Option, Vela paid a one-time, non-refundable option fee to Conduit of $0.5 million (£0.4 million). Total consideration payable to Vela upon exercise of the Vela Put Option is $4.8 million (£4.0 million) worth of shares of New Conduit common stock, following the consummation of the Merger at a price per share equal to the volume-weighted average price per share over the ten (10) business days prior to the date of the notice of the exercise of the option. The Vela Put Option contains a provision that in no event shall the price per share for the consideration shares be lower than $5 or higher than $15. The option is exercisable in whole at any time from the close of the Merger (the “Effective Time”) until the earlier of (i) the date that is six (6) months from the Effective Time, and (ii) February 7, 2024.
I agree that they should leave something in Conduit for the long term, but they have to give up on the 8% commercial interest and take the shares, disposing of a portion. imo anyway
I really appreciate the exact detail being posted here, thank you all. Surely the BOD have to take the profit on this one. Working capital is low for starters. Then maybe we can get back to the kind of vehicle that VELA was always meant to be. I would far rather see a half million in 8 medium-high risk pre IPOs than 4m stuck awaiting long term pharma development.
Wow! Not even close, who's going to take this one?
Excellent, thank you for clarifying.
Thanks BD, but is it at a set share price or a set cash value? In which case the sooner the better.
Forgive my ignorance here, but the board has stated it's intention to exercise the option. I take it that they can and will exercise it right on the bell today.
Halfway to my average here and no reason to suppose that we won't achieve fair value. Going to be a lot of selling into this rise though. I'm going to have to have a very good think about next moves myself after the dust settles and the next statement from the BOD will be key. Hard to trust that they will put new capital to best use after years of dreadful comms and a mix of fair to questionable investments to date. AZD1656 has finally come good but it was a nervy ride to say the least.
A long time since I've posted here. 3+ years in this stock and great to finally have good news, at this rate Airestech might even actually float.
Still below my average here, been here a long time, but this is a nice bit of action. I'm going to stick my neck out here and say it does look like good news on the horizon...
I briefly touched break even today too. In for the ride though. Getting exciting now and I would say that we are all still early. I've always thought about QBT that if they can deliver what they were aiming for then it's massive. Right now it's looking good to me.
Another day like today and I'll also be even
the reason for the uptick in N4P buys today is a tweet from Elon Musk 16 hours ago. Every time he farts in a particular direction it has some financial impact:
Replying to @elonmusk and @BillyM2k
This will make some people upset, but I need to emphasize that accelerating synthetic mRNA technology was another silver lining. It is a revolution in medicine, like going from analog to digital.
The Covid mRNA vaccine dosage level was too high and having a zillion booster shots was idiotic, causing more harm than good imo, but I am convinced that synthetic mRNA is the surest path to curing cancer, among other things.
Been here before and in this share for a long time. Have to hold my nerve...
Looks like AZD 1656 investment is still very much alive, an actual return on that could be transformative for VELA. The price action is a good start but there's a long way to return profit and faith to LTHs. Personally I'll reduce my stake heavily at break even.
I should have known better than to get even vaguely excited on the last spike, seemed leaky but ho hum. I'm not here often now having psychologically plonked VELA in the bottom drawer. However, dipping in I notice from the August RNS that VELA is talking up it's interest in the commercialisation of AZD1656 in terms of a wider autoimmune response and not just in COVID patients which seems to answer a long standing niggle for me in terms of what was in their contract there. The implication is that commercialisation of AZD1656 for any application will return a profit to us, so although that's in a long timeframe it means that this might still not be a bust.